Enno Schmidt

50PUBLICATIONS
184CO-AUTHORS
AllergyPharmacogenomicsAdolescent healthSocial epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 11, 2026
Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

|Jul 24, 2026
Shared Mechanistic Pathways in Bullous Pemphigoid, Chronic Spontaneous Urticaria, Prurigo Nodularis, and Chronic Prurigo of Unknown Origin: Implications for Targeted Therapies.

|Feb 12, 2026
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.

A Nanda, B Tedbirt, C Bodemer

|Nov 15, 2025
Role of protein kinase C subtype-specific signalling in regulating adhesion in human keratinocytes and skin in pemphigus.

Thomas Schmitt, Julia Haneberg, Desalegn Tadesse Egu

|Aug 25, 2025
Anti-p200 pemphigoid.

Michael Kasperkiewicz, Manuela Pigors, Maike M Holtsche

|Aug 06, 2025
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.

Lei Bao, Christian F Guerrero-Juarez, Jing Li

Pageof 9

Frequent Collaborators

13 joint publications

K Patsatsi

11 joint publications

Pascal Joly

10 joint publications

Angelo Valerio Marzano

9 joint publications

Nina Van Beek